These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3278457)
21. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital. Delmonico FL Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062 [No Abstract] [Full Text] [Related]
22. Reversal of accelerated renal allograft rejection with FK 506. Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710 [TBL] [Abstract][Full Text] [Related]
23. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts. Alamartine E; Bellakoul R; Berthoux F Transplant Proc; 1994 Feb; 26(1):273-4. PubMed ID: 8108975 [No Abstract] [Full Text] [Related]
24. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
25. Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation. Abouna GM; Kumar MS; Stephan R; Prior JE; Lyons P; Bulova SI; al-Abdullah IH Transplant Proc; 1993 Jun; 25(3):2241-2. PubMed ID: 8516886 [No Abstract] [Full Text] [Related]
26. Pathology of canine renal allografts prolonged by sheep antilymphocyte plasma. Fox M; Diethelm AG; Glassock RJ; Orr WM; Dubernard JM; Stuart FP; Dammin GJ; Murray JE Invest Urol; 1971 Mar; 8(5):563-74. PubMed ID: 4104119 [No Abstract] [Full Text] [Related]
27. Excellent renal allograft survival in donor-specific antibody transplant patients--role of intravenous immunoglobulin and rabbit antithymocyte globulin. Dhanda R; Shah Y; Bardapure M; Bhattacharjya S; Sharma AK Transplantation; 2009 Aug; 88(3):444. PubMed ID: 19667954 [No Abstract] [Full Text] [Related]
28. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy. Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892 [No Abstract] [Full Text] [Related]
29. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab. Westphal S; Hansson S; Mjörnstedt L; Mölne J; Swerkersson S; Friman S Transplant Proc; 2006 Oct; 38(8):2659-60. PubMed ID: 17098031 [TBL] [Abstract][Full Text] [Related]
31. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression. Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990 [TBL] [Abstract][Full Text] [Related]
32. Positive B lymphocyte crossmatch and glomerular rejection in renal transplant recipients. Russ GR; Nicholls C; Sheldon A; Hay J Transplant Proc; 1987 Feb; 19(1 Pt 1):785-8. PubMed ID: 3547841 [No Abstract] [Full Text] [Related]
33. Prevention of kidney arteriosclerosis: heparin, dipyridamole, warfarin, and plasma exchange. Kincaid-Smith P Transplant Proc; 1987 Aug; 19(4 Suppl 5):82-4. PubMed ID: 3303574 [No Abstract] [Full Text] [Related]
34. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation. Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564 [TBL] [Abstract][Full Text] [Related]
35. Relation of hypertriglyceridaemia to kidney transplant dysfunction and rejection, and response to antilymphocyte globulin therapy. Charlesworth JA; Edwards KD Prog Biochem Pharmacol; 1974; 9():107-20. PubMed ID: 4612555 [No Abstract] [Full Text] [Related]
37. Influence of HLA-DRW6 in the recipient on occurrence of acute rejection of first renal allografts: beneficial influence of antithymocyte globulin as antirejection treatment. Hoitsma AJ; van Lier HJ; Reekers P; Koene RA Transplant Proc; 1984 Oct; 16(5):1156-8. PubMed ID: 6385363 [TBL] [Abstract][Full Text] [Related]
38. [Effect of plasmapheresis in kidney transplantation--a controlled study]. Vangelista A; Frascà GM; di Felice A; Liviano d'Arcangelo G; Bonomini V Z Urol Nephrol; 1986 Jun; 79(6):311-6. PubMed ID: 3529744 [TBL] [Abstract][Full Text] [Related]